Epam (EPAM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Epam reported Q3 2026 revenue of $1.43 billion, up 2.3% year-over-year, beating consensus estimates by 0.56%. EPS of $3.51 exceeded the $3.41 estimate by 2.93%. Key strengths included strong growth in Financial Services (+13.7%), Life Sciences & Healthcare (+9.9%), and Fixed-price contracts (+17.8%), though Software & Hi-Tech declined 6.1%. The stock has gained 26.8% over the past month and holds a Zacks Rank #3 (Hold) rating.